About ALDOCK

About company

ALDOCK develops a groundbreaking risk test that will help in the early detection of cancer. The company is conducting research and development of risk tests that will help in the early detection of cancer. ALDOCK analyzes biomarker measurement results by machine learning to constantly improve inspection accuracy, and also construct an NGS analysis pipeline for that purpose. It provides a secure API / SDK that can be shared with other applications, as well as the inspection result can be confirmed by the user from the application.